MuCaP379.1 Cells

Unit

1×10⁶ cells / 1.0 ml

Cell Type

Tumor Cells

Tissue Type

Prostate

Organism

Mouse (M. musculus)

Donor History

Mouse prostate cancer

,

PSA-Cre;PtenLoxP/LoxP genetic engineered mouse model (GEMM)

Growth Properties

Adherent

,

epithelial

Growth Conditions

PriCoat™ ECM T25 Flasks (G999) or Applied Cell Extracellular Matrix (G422) are required for cell adhesion to the culture vessels. PriGrow II (TM002) + 10% FBS + 1% Penicillin/Streptomycin Solution (G255)

,

37.0°C

,

5% CO₂. 

Immortalization Method

Tumor Cell Line

Full Information

https://www.abmgood.com/mucap379-1-cells.html

Katalogové číslo: T8304 Kategorie: ,
Popis

MuCaP379.1 is an epithelial prostate cancer cell line also derived from the same primary Pten KO tumor as MuCaP379AP. It forms syngeneic tumors very slowly, often requiring extended periods for tumor detection in immunocompetent mice. This cell line resembles the histological heterogeneity of the original tumor and predominantly exhibits an adenocarcinoma phenotype with high CK8 expression. MuCaP379.1 shows high levels of CD3+ T-cell and CD8+ effector T-cell infiltration, along with an immune gene profile marked by expressions of IFNγ and PD1, correlating with less aggressive tumor behavior. MuCaP379.1 cell line proliferation is barely detectable and has an adenocarcinoma growth pattern with subcutaneous injection. This cell line is particularly useful for examining the immune landscape of prostate tumors and testing immune-based therapeutic approaches in a genetically defined model system.Additional cell lines from the MuCaP model: Cat. T8301 – MuCaP321 CellsCat. T8302 – MuCaP376 CellsCat. T8303 – MuCaP379AP Cells

O značce
Applied Biological Materials (abm) je jedním z našich klíčových dodavatelů pro biotechnologický průmysl. Společnost byla založena v roce 2004 a již více než deset let podporuje vědecké objevy v oblasti přírodních věd a vývoje léčiv. Její sídlo se nachází ve Vancouveru v Kanadě. ABM je pro nás neocenitelným partnerem zejména v  oblasti dodávek buněčných kultur, genových a virových vektorů, produktů pro molekulární biologii a PCR, nástrojů pro technologie CRISPR a RNAi, protilátek i základních reagencií pro molekulárně genetické procesy.